NMAD
NOMAD Power Solutions, Inc.
There isn't enough reported data to score NMAD yet.
NMAD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
NMAD's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NMAD PE Valuation
NMAD has no meaningful PE right now: it lost money over the past year.
NMAD Forward outlook
There aren't enough analyst estimates for NMAD to show an outlook.
NMAD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.02 | +$0.27 |
| Q1 2026 | -$1.15 | +$0.30 |
| Q4 2025 | -$1.26 | +$0.33 |
| Q3 2025 | -$1.18 | +$0.64 |
| Q2 2025 | -$1.29 | +$0.58 |
| Q1 2025 | -$1.45 | +$0.97 |
| Q4 2024 | -$1.59 | +$1.20 |
| Q3 2024 | -$1.82 | +$1.50 |
NMAD is still losing money, but far less than before: $1.02 per share over the past year, against $5.00 at its worst in late 2021.
NMAD Quarterly Revenue
NMAD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.6M | -$1.1M |
| Q1 2026 | -$1.8M | -$1.3M |
| Q4 2025 | -$1.1M | -$489.2K |
| Q3 2025 | -$926.8K | +$30.8K |
| Q2 2025 | -$487.5K | +$331.6K |
| Q1 2025 | -$568.5K | +$220.7K |
| Q4 2024 | -$598.7K | +$303.4K |
| Q3 2024 | -$957.6K | -$13.2K |
NMAD has burned cash in almost every quarter: −$5M over the past year, against −$3M the year before.
NMAD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +2.6M shares |
| 1 year | +445% | +11M shares |
| 3 years | +709% | +11.8M shares |
| 5 years | +955% | +12.2M shares |
| Available history | +1106% | +12.4M shares |
NMAD has 13M diluted shares, up 445% from a year ago.
NMAD Net Leverage
NMAD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NMAD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 29.9 | Neutral |
NMAD's weekly RSI is 44 (neutral) and its Stochastic is 30 (neutral).
NMAD PE vs Healthcare Sector
NMAD has no meaningful PE right now: it lost money over the past year.
NMAD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.85 | 3.9% below |
| 20 week MA | $4.34 | 15% below |
| 50 week MA | $4.23 | 13% below |
| 100 week MA | $3.52 | 5.1% above |
| 200 week MA | $3.56 | 3.9% above |
NMAD has slipped below its 8-, 20- and 50-week averages, though it's still 3.9% above its 200-week average.
NMAD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.0 | $35.3 | -16% |
| 2021 | $35.3 | $12.4 | -65% |
| 2022 | $12.4 | $5.00 | -60% |
| 2023 | $5.00 | $2.35 | -53% |
| 2024 | $2.35 | $2.00 | -15% |
| 2025 | $2.00 | $4.07 | +104% |
| 2026 YTD | $4.07 | $3.70 | -9.1% |
NMAD's yearly returns have swung widely, from +104% in 2025 to −65% in 2021. It's down 9.1% so far in 2026.